Search Results - "Yaxley, John"

Letter: Perioperative, Oncological, and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial by Yaxley, John W.

Get full text

Focal irreversible electroporation for treatment of primary and radio‐recurrent prostate cancer – the evidence is mounting by Yaxley, John W.

Get full text

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study by Yaxley, John W, FRACS, Coughlin, Geoffrey D, FRACS, Chambers, Suzanne K, Prof, Occhipinti, Stefano, PhD, Samaratunga, Hema, FRCPA, Zajdlewicz, Leah, MOrgPsych, Dunglison, Nigel, FRACS, Carter, Rob, Prof, Williams, Scott, MBBS, Payton, Diane J, FRCPA, Perry-Keene, Joanna, FRCPA, Lavin, Martin F, Prof, Gardiner, Robert A, Prof

“…Summary Background The absence of trial data comparing robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy is a crucial…”
Get full text

Will Favourable Functional Results with Salvage Robot-assisted Laparoscopic Radical Prostatectomy Increase the Uptake of Primary Focal Therapy for Localised Prostate Cancer? by Yaxley, John W.

Get full text

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study by Coughlin, Geoffrey D, Yaxley, John W, Chambers, Suzanne K, Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Teloken, Patrick, Dunglison, Nigel, Williams, Scott, Lavin, Martin F, Gardiner, Robert A

“…Previous trials have found similar early outcomes after robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy. We report…”
Get full text

Level 1 Evidence of Better Early Urinary Continence at 3 Months Following Robot-assisted Laparoscopic Radical Prostatectomy Compared with Laparoscopic Radical Prostatectomy. Results of the LAP-01 Randomised Controlled Trial by Yaxley, John W., Coughlin, Geoff, Patel, Vipul

Get full text

Comparison between target magnetic resonance imaging (MRI) in‐gantry and cognitively directed transperineal or transrectal‐guided prostate biopsies for Prostate Imaging–Reporting and Data System (PI‐RADS) 3–5 MRI lesions by Yaxley, Anna J., Yaxley, John W., Thangasamy, Isaac A., Ballard, Emma, Pokorny, Morgan R.

“…Objective To compare the detection rates of prostate cancer (PCa) in men with Prostate Imaging–Reporting and Data System (PI‐RADS) 3–5 abnormalities on 3‐Tesla…”
Get full text

Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic Parameter by Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John W., Johannsen, Shulammite, Egevad, Lars

“…High-grade prostatic adenocarcinoma involving duct/acinar structures is labeled intraductal carcinoma of the prostate (IDCP). As numerous studies have shown…”
Get full text

Clinicopathologic Significance of Anterior Prostate Cancer: Comparison With Posterior Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging by Samaratunga, Hemamali, Egevad, Lars, Yaxley, John W., Johannsen, Shulammite, Le Fevre, Ian K., Perry-Keene, Joanna L., Gianduzzo, Troy, Chabert, Charles, Coughlin, Gregory, Parkinson, Robert, Kua, Boon, Yaxley, William, Delahunt, Brett

“…Anterior prostate cancer (APC) has been considered an indolent tumor, most commonly arising in the transition zone (TZ). More recently, detection of APC has…”
Get full text

In Reply: Intraductal Carcinoma of the Prostate and Nuclear Size by Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John W., Johannsen, Shulammite, Egevad, Lars

Get full text

Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study by Yaxley, William John, Gianduzzo, Troy, Kua, Boon, Oxford, Rachel, Yaxley, John William

“…Focal irreversible electroporation (IRE) for prostate cancer aims to reduce quality of life complications, however outcomes data remains limited. We aimed to…”
Get full text

Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction by Koo, Kevin M, Wang, Jing, Richards, Renée S, Farrell, Aine, Yaxley, John W, Samaratunga, Hema, Teloken, Patrick E, Roberts, Matthew J, Coughlin, Geoffrey D, Lavin, Martin F, Mainwaring, Paul N, Wang, Yuling, Gardiner, Robert A, Trau, Matt

“…The use of emerging nanotechnologies, such as plasmonic nanoparticles in diagnostic applications, potentially offers opportunities to revolutionize disease…”
Get full text

Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading by Dagher, Julien, Delahunt, Brett, Rioux‐Leclercq, Nathalie, Egevad, Lars, Srigley, John R, Coughlin, Geoffrey, Dunglinson, Nigel, Gianduzzo, Troy, Kua, Boon, Malone, Greg, Martin, Ben, Preston, John, Pokorny, Morgan, Wood, Simon, Yaxley, John, Samaratunga, Hemamali

“…Aims In 2012, the International Society of Urological Pathology (ISUP) introduced a novel grading system for clear cell renal cell carcinoma (ccRCC) and…”
Get full text

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era? by Roberts, Matthew J, Yaxley, John W, Stranne, Johan, van Oort, Inge M, Tilki, Derya

Get full text

External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study by Meijer, Dennie, van Leeuwen, Pim J., Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Oprea-Lager, Daniela E., Coughlin, Geoffrey D., Vis, André N.

“…Different nomograms exist for the preoperative prediction of pelvic lymph-node metastatic disease in individual patients with prostate cancer (PCa). These…”
Get full text

Staging of renal cell carcinoma: current progress and potential advances by Delahunt, Brett, Eble, John N., Samaratunga, Hemamali, Thunders, Michelle, Yaxley, John W., Egevad, Lars

“…Formal staging classifications for renal cell carcinoma (RCC) were first proposed in 1978 and were incorporated into the Tumour, Nodes, Metastases (TNM) system…”
Get full text

The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma by Raveenthiran, Sheliyan, Esler, Rachel, Yaxley, John, Kyle, Sam

“…Purpose The role of 68 Ga-PSMA PET/CT in the staging of prostate cancer is well known. PSMA is also overexpressed in the neovasculature of other tumours…”
Get full text

Long‐term outcomes of high‐dose‐rate brachytherapy for intermediate‐ and high‐risk prostate cancer with a median follow‐up of 10 years by Yaxley, John W., Lah, Kevin, Yaxley, Julian P., Gardiner, Robert A., Samaratunga, Hema, MacKean, James

“…Objective To evaluate the long‐term outcomes of high‐dose‐rate (HDR) brachytherapy for patients with intermediate‐ and high‐risk prostate cancer. Subjects and…”
Get full text

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy by Roberts, Matthew J., Morton, Andrew, Papa, Nathan, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, McEwan, Louise, Wong, David, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Brown, Nicholas, Parkinson, Robert, Emmett, Louise, Yaxley, John W.

“…Purpose The prognostic value of PSMA intensity on PSMA PET/CT due to underlying biology and subsequent clinical implications is an emerging topic of interest…”
Get full text

The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison by Tariq, Arsalan, Kwok, Michael, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Marsh, Phillip, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Westera, Jurjen, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A., Roberts, Matthew J.

“…•Dual Tracer PET demonstrates clinical utility in staging & restaging of renal cancer.•PSMA and FDG offer complimentary roles due to differing mechanisms of…”
Get full text